Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Andrew Walker. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Walker or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Anek Capital's Orel Levy's Cellebrite Thesis $CLBT

1:00:21
 
Share
 

Manage episode 497721723 series 2789730
Content provided by Andrew Walker. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Walker or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of Yet Another Value Podcast, host Andrew Walker is joined by Orel Levy of Anek Capital to discuss Cellebrite (ticker: CLBT). The conversation explores Cellebrite’s digital forensics tools, from cracking phones to managing and analyzing data. Orel provides a comprehensive overview of Cellebrite's business model, competitive positioning, and potential for growth. Topics include their shift to a SaaS model, the federal sector's role, AI integration, competitive threats like Palantir, and the company’s broader strategic outlook. They also touch on risks, including execution challenges, management turnover, and potential M&A speculation. Tune in to understand why Cellebrite is at the intersection of technology, law enforcement, and investing.

If you're interested in the CLBT trata call mentioned during the podcast, see: https://www.trytrata.com/clbt____________________________________________________________

[00:00:00] Podcast intro and sponsor mention

[00:03:13] Cellebrite's history and pivot

[00:06:08] Phone cracking explained

[00:07:18] R&D moat and customer stickiness

[00:08:40] Valuation versus growth peers

[00:09:52] SPAC history and misunderstood model

[00:13:41] iPhone cracking and misconceptions[00:15:03] Apple, Google cooperation risk

[00:16:29] Growth potential and market size

[00:21:27] Management turnover and CEO plans

[00:27:38] Sale speculation and strategic fit

[00:30:49] Mission-critical usage example

[00:31:51] Federal budget and deployments

[00:33:52] Event-driven budget growth potential

[00:37:47] Guardian, Pathfinder, cloud ramping

[00:42:58] Long-term risks: execution concerns

[00:50:43] AI: neutral impact for now

[00:53:39] Suncorp ownership and sale pressure

[00:57:46] Ethics and private sector risks

[01:00:00] Wrap-up and future conversations

Links:If you're interested⁠ in the CLBT trata call mentioned during the podcast⁠, see: https://www.trytrata.com/clbt

Yet Another Value Blog: https://www.yetanothervalueblog.com

See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer

  continue reading

342 episodes

Artwork
iconShare
 
Manage episode 497721723 series 2789730
Content provided by Andrew Walker. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Walker or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of Yet Another Value Podcast, host Andrew Walker is joined by Orel Levy of Anek Capital to discuss Cellebrite (ticker: CLBT). The conversation explores Cellebrite’s digital forensics tools, from cracking phones to managing and analyzing data. Orel provides a comprehensive overview of Cellebrite's business model, competitive positioning, and potential for growth. Topics include their shift to a SaaS model, the federal sector's role, AI integration, competitive threats like Palantir, and the company’s broader strategic outlook. They also touch on risks, including execution challenges, management turnover, and potential M&A speculation. Tune in to understand why Cellebrite is at the intersection of technology, law enforcement, and investing.

If you're interested in the CLBT trata call mentioned during the podcast, see: https://www.trytrata.com/clbt____________________________________________________________

[00:00:00] Podcast intro and sponsor mention

[00:03:13] Cellebrite's history and pivot

[00:06:08] Phone cracking explained

[00:07:18] R&D moat and customer stickiness

[00:08:40] Valuation versus growth peers

[00:09:52] SPAC history and misunderstood model

[00:13:41] iPhone cracking and misconceptions[00:15:03] Apple, Google cooperation risk

[00:16:29] Growth potential and market size

[00:21:27] Management turnover and CEO plans

[00:27:38] Sale speculation and strategic fit

[00:30:49] Mission-critical usage example

[00:31:51] Federal budget and deployments

[00:33:52] Event-driven budget growth potential

[00:37:47] Guardian, Pathfinder, cloud ramping

[00:42:58] Long-term risks: execution concerns

[00:50:43] AI: neutral impact for now

[00:53:39] Suncorp ownership and sale pressure

[00:57:46] Ethics and private sector risks

[01:00:00] Wrap-up and future conversations

Links:If you're interested⁠ in the CLBT trata call mentioned during the podcast⁠, see: https://www.trytrata.com/clbt

Yet Another Value Blog: https://www.yetanothervalueblog.com

See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer

  continue reading

342 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play